This brand name is authorized in Ecuador
The drug BISMUSAL contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Sodium bicarbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE
|
|
Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide. |
|
2
Magnesium sulfate
UNII DE08037SAB - MAGNESIUM SULFATE, UNSPECIFIED FORM
|
|
Magnesium sulfate is a saline purgative. It can be employed locally in various inflammatory conditions, due to its osmotic action. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A02AA10 | Combinations | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids → A02AA Magnesium compounds |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 3228-MEN-0621 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
